Protara Therapeutics
Clinical trials sponsored by Protara Therapeutics, explained in plain language.
-
New bladder cancer drug shows promise in early trial
Disease control Recruiting nowThis study tests a new drug, TARA-002, given directly into the bladder for people with a high-grade type of bladder cancer that hasn't spread into the muscle. The goal is to see if it can make the cancer disappear and keep it away. About 131 adults who have not had enough success…
Phase: PHASE2 • Sponsor: Protara Therapeutics • Aim: Disease control
Last updated May 17, 2026 04:49 UTC
-
New injection could fix nutrient deficiency in intestinal failure patients
Disease control Recruiting nowThis study tests an injection of choline chloride in adolescents and adults with intestinal failure who rely on long-term intravenous nutrition. The goal is to see if the drug can safely raise choline levels and reduce liver injury. About 129 participants will receive either a lo…
Phase: PHASE2, PHASE3 • Sponsor: Protara Therapeutics • Aim: Disease control
Last updated May 17, 2026 04:48 UTC
-
New injection could shrink painful cysts in kids without surgery
Disease control Recruiting nowThis study tests a medicine called TARA-002 that is injected directly into fluid-filled lumps (lymphatic malformations) in children aged 6 months to 18 years. The goal is to see if it can safely shrink or eliminate these cysts, which can cause pain and breathing problems. Up to 3…
Phase: PHASE2 • Sponsor: Protara Therapeutics • Aim: Disease control
Last updated May 13, 2026 16:02 UTC